You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 21, 2025

Drug Price Trends for COUGH DM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for COUGH DM

Average Pharmacy Cost for COUGH DM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
COUGH DM ER 30 MG/5 ML SUSP 46122-0141-25 0.04947 ML 2025-06-18
COUGH DM ER 30 MG/5 ML SUSP 70000-0302-01 0.06402 ML 2025-06-18
COUGH DM 20-200 MG/20 ML SYRUP 00536-1348-97 0.01686 ML 2025-06-18
COUGH DM ER 30 MG/5 ML SUSP 70000-0187-01 0.06402 ML 2025-06-18
COUGH DM ER 30 MG/5 ML SUSP 00904-6312-56 0.06402 ML 2025-06-18
COUGH DM ER 30 MG/5 ML SUSP 46122-0141-21 0.06402 ML 2025-06-18
COUGH DM ER 30 MG/5 ML SUSP 46122-0141-25 0.04913 ML 2025-05-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Cough Suppressants: Focus on Dextromethorphan

Introduction to Cough Suppressants

Cough suppressants, including those containing dextromethorphan, are a crucial segment of the pharmaceutical market, particularly in the context of treating respiratory conditions such as the common cold, flu, bronchitis, and allergies. Here, we delve into the market dynamics, growth drivers, and price projections for these medications.

Global Market Size and Growth

The global cough suppressant market is experiencing significant growth, driven by several key factors. As of 2023, the global cough suppressant market was valued at USD 25,561.3 million and is projected to reach USD 50,948.51 million by 2034, growing at a CAGR of 6.5% during the forecast period[3].

Dextromethorphan Market Specifics

The dextromethorphan market, a subset of the cough suppressant market, was valued at USD 487.25 million in 2022 and is expected to grow to USD 587.31 million by 2030, with a CAGR of 4.8% during the forecast period of 2023 to 2030. Over-the-counter (OTC) products dominate this segment due to high consumer demand[1].

Drivers of Market Growth

Increasing Prevalence of Cough-Related Conditions

The rising prevalence of respiratory conditions such as the common cold, flu, bronchitis, and allergies is a significant driver of the market. These conditions increase the demand for cough medications, thereby boosting the growth of the dextromethorphan market[1].

Growing Consumer Awareness and Self-Medication

Increased access to healthcare information has led to greater consumer awareness and a rise in self-medication practices. This trend encourages individuals to seek relief from cough symptoms using OTC medications like dextromethorphan, contributing to market growth[1].

Technological Advancements in Drug Delivery Systems

Innovations in drug delivery systems, such as improved formulations and combination products, have enhanced the efficacy and convenience of cough medications. These advancements attract consumers and contribute to market expansion[1].

Regional Outlook

Dominant Regions

The Asia-Pacific region holds the largest revenue share in the cough syrup market, including cough suppressants. This dominance is attributed to the easy availability of cough syrups, an increasing geriatric population, and relatively lenient regulations regarding the use of cough and cold medicines[2].

North America

North America is expected to show significant growth in the cough suppressant market, driven by frequent FDA approvals of new cough suppressant drugs. For instance, approvals for products like Mucinex DM Maximum Strength and Tuzistra XR have contributed to market growth in this region[4].

Product Outlook

Cough Suppressants Segment

Cough suppressants, which include dextromethorphan, hold the highest share in the cough syrup market. The general availability of dextromethorphan at medical stores and pharmacies is a key factor driving this segment's growth[2].

Price Projections and Affordability

Current Pricing

The cost of cough suppressants like Tussin DM, which contains dextromethorphan and guaifenesin, varies but is generally affordable. For example, a supply of 118 milliliters of Tussin DM oral liquid can cost between $10 to $12, depending on the pharmacy[5].

Future Pricing Trends

Given the projected growth of the market, prices are likely to remain competitive due to the presence of generic versions and various discount programs. However, any significant advancements in formulations or delivery systems could slightly increase prices, though they are expected to remain within an affordable range for most consumers.

Opportunities and Challenges

Expansion of the Pharmaceutical Industry

The growing pharmaceutical industry, driven by advancements in drug development and increasing investments in research and development, presents opportunities for the dextromethorphan market. This growth is expected to continue, driven by expanding healthcare infrastructure and strategic collaborations between public and private players[1].

Rising Competition

The market faces competition from various other cough and cold medications, which can impact the growth of dextromethorphan-containing products. However, the established brand presence and consumer trust in dextromethorphan-based products help mitigate this challenge[1].

Key Players and Innovations

Key players in the market are investing heavily in the innovation of new drugs and formulations. For instance, the approval and launch of products like Mucinex DM Maximum Strength have driven market growth. These players are also advancing the market through diverse methodologies for clinical trials and the development of standardized medicines that meet patient outcomes[4].

Regulatory Framework

The regulatory environment, particularly in regions like North America, plays a crucial role in the market's growth. Frequent FDA approvals for new cough suppressant drugs are a significant factor in the market's expansion. Compliance with strict regulations ensures the development of safe and effective medications, which in turn boosts consumer confidence and market growth[4].

Consumer Behavior and Preferences

Consumers are increasingly seeking effective and convenient cough medications. The preference for OTC products, especially those containing dextromethorphan, is high due to their ease of access and proven efficacy. This consumer behavior is expected to continue driving the market forward[1].

Seasonal Variations and Demand

Seasonal variations, such as the monsoon season, significantly impact the demand for cough suppressants. During these periods, the viability of bacteria causing cough and cold increases, leading to higher demand for medications like dextromethorphan[3].

Key Takeaways

  • The global cough suppressant market, including dextromethorphan, is projected to grow significantly, driven by increasing prevalence of respiratory conditions and consumer awareness.
  • The Asia-Pacific region dominates the market due to easy availability and lenient regulations.
  • North America shows promising growth due to frequent FDA approvals of new drugs.
  • Technological advancements in drug delivery systems enhance market growth.
  • Prices are expected to remain competitive with the availability of generic versions and discount programs.

FAQs

What is the current market size of the global dextromethorphan market?

The global dextromethorphan market was valued at USD 487.25 million in 2022[1].

What is the projected growth rate of the global cough suppressant market?

The global cough suppressant market is expected to grow at a CAGR of 6.5% from 2024 to 2034[3].

Which region dominates the cough syrup market?

The Asia-Pacific region holds the largest revenue share in the cough syrup market[2].

What are the key drivers of the dextromethorphan market?

Key drivers include the increasing prevalence of cough-related conditions, growing consumer awareness and self-medication, and technological advancements in drug delivery systems[1].

How does the regulatory environment impact the market?

Frequent FDA approvals for new cough suppressant drugs in regions like North America significantly drive market growth and ensure the development of safe and effective medications[4].

What is the typical cost of a cough suppressant like Tussin DM?

The cost of Tussin DM oral liquid can range from $10 to $12 for a supply of 118 milliliters, depending on the pharmacy[5].

Sources

  1. Data Bridge Market Research: Global Dextromethorphan Market – Industry Trends and Forecast to 2030.
  2. KBV Research: Cough Syrup Market Size, Trends & Growth Forecast 2020-2026.
  3. Future Market Insights: Cough Suppressant Market Demand & Growth Analysis 2034.
  4. Coherent Market Insights: Cough Suppressant Drugs Market - Price, Size, Share & Growth.
  5. Drugs.com: Tussin DM Prices, Coupons, Copay Cards & Patient Assistance.
Last updated: 2024-12-30

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.